Detalles de la búsqueda
1.
Radiotheranostics in oncology: Making precision medicine possible.
CA Cancer J Clin
; 73(3): 255-274, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36622841
2.
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Proc Natl Acad Sci U S A
; 119(27): e2203820119, 2022 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35759660
3.
A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.
Prostate
; 84(4): 395-402, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108113
4.
Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
Cancer
; 130(9): 1609-1617, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38146764
5.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
J Urol
; 211(4): 526-532, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421252
6.
Prostate cancer and elective nodal radiation therapy for cN0 and pN0-a never ending story? : Recommendations from the prostate cancer expert panel of the German Society of Radiation Oncology (DEGRO).
Strahlenther Onkol
; 200(3): 181-187, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273135
7.
Effect of simultaneous integrated boost concepts on photoneutron and distant out-of-field doses in VMAT for prostate cancer.
Strahlenther Onkol
; 200(3): 219-229, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37707518
8.
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation.
Strahlenther Onkol
; 200(3): 188-194, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37341774
9.
Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
Strahlenther Onkol
; 200(3): 195-201, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626226
10.
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patients.
Strahlenther Onkol
; 200(3): 208-218, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658924
11.
Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
Strahlenther Onkol
; 200(3): 239-249, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38180492
12.
Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy.
Strahlenther Onkol
; 200(3): 230-238, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38157016
13.
Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
Oncology
; 102(3): 283-290, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806307
14.
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 51(2): 558-567, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37736808
15.
Extended nodal radiotherapy for prostate cancer relapse guided with [11C]-choline PET/CT: ten-year results in patients enrolled in a prospective trial.
Eur J Nucl Med Mol Imaging
; 51(2): 590-603, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37747578
16.
Comparison of sexual function after robot-assisted radical prostatectomy and carbon-ion radiotherapy for Japanese prostate cancer patients using propensity score matching.
BMC Cancer
; 24(1): 300, 2024 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38443871
17.
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer.
BMC Cancer
; 24(1): 431, 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589860
18.
Synthesis and Preclinical Evaluation of PSMA-Targeted 111In-Radioconjugates Containing a Mitochondria-Tropic Triphenylphosphonium Carrier.
Mol Pharm
; 21(1): 216-233, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37992229
19.
The Dedicated Imaging Post-Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low-risk biochemical recurrence after radical prostatectomy.
BJU Int
; 133 Suppl 3: 39-47, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37604702
20.
Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".
World J Urol
; 42(1): 169, 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38492078